| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 7.596 | 56.590 | 89.116 | 119.321 | 133.726 | 176.904 | 199.076 | 262.528 | 257.414 | 250.085 |
| Total Income - EUR | 7.596 | 56.590 | 89.120 | 119.323 | 133.790 | 176.924 | 199.093 | 262.532 | 257.415 | 250.087 |
| Total Expenses - EUR | 12.044 | 52.334 | 84.543 | 106.081 | 113.694 | 147.441 | 164.511 | 220.960 | 222.992 | 219.634 |
| Gross Profit/Loss - EUR | -4.448 | 4.256 | 4.577 | 13.241 | 20.096 | 29.483 | 34.582 | 41.572 | 34.423 | 30.454 |
| Net Profit/Loss - EUR | -4.676 | 3.690 | 3.686 | 12.048 | 18.758 | 27.844 | 32.631 | 39.055 | 32.233 | 24.832 |
| Employees | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 3 |
Check the financial reports for the company - Oituz Pharma Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 2.045 | 1.450 | 1.082 | 822 | 938 | 1.944 | 1.680 | 1.896 | 1.398 | 1.730 |
| Current Assets | 6.821 | 14.348 | 15.769 | 30.057 | 42.755 | 72.422 | 107.473 | 119.359 | 154.400 | 120.555 |
| Inventories | 6.536 | 12.496 | 8.803 | 12.297 | 12.132 | 20.079 | 23.510 | 22.449 | 35.492 | 25.571 |
| Receivables | 0 | 0 | 4.791 | 5.024 | 4.231 | 7.910 | 11.367 | 22.452 | 13.345 | 12.511 |
| Cash | 285 | 1.852 | 2.175 | 12.736 | 26.391 | 44.433 | 72.596 | 74.458 | 105.563 | 82.473 |
| Shareholders Funds | -4.631 | -893 | 2.808 | 14.804 | 33.276 | 60.489 | 91.778 | 98.470 | 130.405 | 93.716 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 13.496 | 16.691 | 14.043 | 16.075 | 10.417 | 13.878 | 17.376 | 22.785 | 25.393 | 28.569 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Oituz Pharma Srl